General Information of Drug Off-Target (DOT) (ID: OT2FTK68)

DOT Name Pleckstrin homology domain-containing family O member 2 (PLEKHO2)
Synonyms PH domain-containing family O member 2; Pleckstrin homology domain-containing family Q member 1; PH domain-containing family Q member 1
Gene Name PLEKHO2
UniProt ID
PKHO2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00169
Sequence
MEEEGVKEAGEKPRGAQMVDKAGWIKKSSGGLLGFWKDRYLLLCQAQLLVYENEDDQKCV
ETVELGSYEKCQDLRALLKRKHRFILLRSPGNKVSDIKFQAPTGEEKESWIKALNEGINR
GKNKAFDEVKVDKSCALEHVTRDRVRGGQRRRPPTRVHLKEVASAASDGLLRLDLDVPDS
GPPVFAPSNHVSEAQPRETPRPLMPPTKPFLAPETTSPGDRVETPVGERAPTPVSASSEV
SPESQEDSETPAEEDSGSEQPPNSVLPDKLKVSWENPSPQEAPAAESAEPSQAPCSETSE
AAPREGGKPPTPPPKILSEKLKASMGEMQASGPPAPGTVQVSVNGMDDSPEPAKPSQAEG
TPGTPPKDATTSTALPPWDLPPQFHPRCSSLGDLLGEGPRHPLQPRERLYRAQLEVKVAS
EQTEKLLNKVLGSEPAPVSAETLLSQAVEQLRQATQVLQEMRDLGELSQEAPGLREKRKE
LVTLYRRSAP
Reactome Pathway
Neutrophil degranulation (R-HSA-6798695 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
15 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [1]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [2]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [3]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [4]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [5]
Menadione DMSJDTY Approved Menadione affects the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [6]
Dexamethasone DMMWZET Approved Dexamethasone increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [7]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [8]
Tocopherol DMBIJZ6 Phase 2 Tocopherol increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [9]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [10]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [11]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [12]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [13]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [15]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 15 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Pleckstrin homology domain-containing family O member 2 (PLEKHO2). [14]
------------------------------------------------------------------------------------

References

1 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
2 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
3 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
4 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
5 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
6 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
7 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
8 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
9 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
10 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
11 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
12 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
13 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
14 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
15 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
16 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.